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Generalized vitiligo is a common, autoimmune, familial-clustering depigmentary disorder of the skin and hair that
results from selective destruction of melanocytes. Generalized vitiligo is likely a heterogeneous disease, with five
susceptibility loci reported so far—on chromosomes 1p31, 6p21, 7q, 8p, and 17p13—in white populations. To
investigate vitiligo susceptibility loci in the Chinese population, we performed a genomewide linkage analysis in
57 multiplex Chinese families, each with at least two affected siblings, and we identified interesting linkage evidence
on 1p36, 4q13-q21, 6p21-p22, 6q24-q25, 14q12-q13, and 22q12. Subsequently, to extract more linkage infor-
mation, we investigated our initial genomewide linkage findings in a follow-up analysis of 49 new families and
additional markers. Our initial genomewide linkage analysis and our subsequent follow-up analysis have identified
a novel linkage to vitiligo on 4q13-q21, with highly significant linkage evidence (a nonparametic LOD score of
4.62 [ ] and a heterogeneity LOD score of 4.01, under a recessive inheritance model), suggesting thatPp .000003
4q13-q21 likely harbors a major susceptibility locus for vitiligo in the Chinese population. We observed a minimal
overlap between the linkage results of our current genomewide analysis in the Chinese population and the results
of previous analyses in white populations, and we thus hypothesize that, as a polygenic disorder, vitiligo may be
associated with great genetic heterogeneity and a substantial difference in its genetic basis between ethnic
populations.
Generalized vitiligo (MIM 193200) is a common ac-
quired autoimmune disorder of skin and hair that results
from selective destruction of melanocytes (Cho et al.
2000). It is characterized by the appearance of sharply
delimited patches of white skin overlying hair, oral mu-
cosa, and occasionally the eyes, which are due to non-
inflammatory loss of pigment-forming melanocytes in
affected areas. Vitiligo is associated with autoimmune
disorders such as hypothyroidism, diabetes mellitus,
chronic active hepatitis, pernicious anemia, and adrenal
insufficiency (Kovacs 1998). The population prevalence
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of vitiligo ranges from 0.1% to 2% and shows a wide
variability among ethnic groups (Bolognia et al. 1998;
Hann and Nordlund 2000). For example, whereas the
estimated population prevalence of vitiligo is ∼0.38%
for whites in the United States and northern Europe
(Howitz et al. 1977), vitiligo affects only ∼0.19% of the
population in China (Xu et al. 2002).
Genetic risk for vitiligo is well supported by multiple
lines of evidence. Vitiligo is frequently associated with
familial clustering (Mehta et al. 1973; Carnevale et al.
1980; Goudie et al. 1983; Hafez et al. 1983; Das et al.
1985; Majumder et al. 1993; Alkhateeb et al. 2003),
and ∼20% of probands have at least one affected first-
degree relative (Alkhateeb et al. 2003). The risk for first-
degree relatives of patients with vitiligo to develop the
disease is elevated by 7- to 10-fold (Nath et al. 1994)
compared with the risk for the general population. Sim-
ilarly, our recent study of the Chinese population indi-
cated that ∼1.8% of patients’ first-degree relatives were
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Table 1
Summary of Analyses of Families
ANALYSIS
TOTAL NO. OF
NO. OF FAMILIES BY NO. OF AFFECTEDS
(TOTAL NO. OF AFFECTEDS)
Families Affecteds Two Affecteds Three Affecteds Four or More Affecteds
Initial genomewide scan 57 172 23 (46) 17 (51) 17 (75)
Follow-up 49 114 35 (70) 12 (36) 2 (8)
Combined 106 286 58 (116) 29 (87) 19 (83)
affected with vitiligo, which was 9-fold higher than the
prevalence rate in general population (Zhang et al.
2004b). In addition, segregation analysis suggested that
vitiligo is a multifactorial and polygenic disorder that
likely results from multiple genetic and environmental
factors (Arcos-Burgos et al. 2002; Alkhateeb et al. 2003;
Zhang et al. 2004b). However, no disease genes have
been identified for vitiligo so far.
Several genomewide linkage analyses of vitiligo have
been performed in the past few years, and multiple link-
ages to vitiligo have been identified (Nath et al. 2001;
Alkhateeb et al. 2002; Fain et al. 2003; Spritz et al. 2004).
Using 16 European American pedigrees with cosegrega-
tion of systemic lupus erythematosus and vitiligo, Nath
et al. (2001) performed the first genomewide linkage anal-
ysis of vitiligo and identified a significant linkage on
17p13. Shortly afterwards, Spritz and his colleagues per-
formed a series of genomewide linkage analyses of vitiligo
in white families. Their initial genomewide scan was done
in a three-generation multiplex family with cosegregation
of vitiligo and Hashimoto thyroiditis, and they identified
a candidate gene with highly significant linkage at a locus
(named “AIS1”) on chromosome 1p32.2-p31.3 (Alkha-
teeb et al. 2002). Subsequently, they performed a follow-
up genomewide linkage analysis by studying 70 additional
white families (Fain et al. 2003). Their follow-up analysis
confirmed the original linkage finding at the AIS1 locus
with highly significant linkage evidence (nonparametric
LOD [NPL] score of 5.56) and identified additional link-
age evidence on chromosomes 1, 7, 8, 11, 19, and 22.
More recently, the group performed an extended ge-
nomewide linkage analysis, using 102 multiplex families
(including the 70 families used in the previous genome-
wide scan) (Spritz et al. 2004). The linkage results from
the 102 families reinforced the strong support for the AIS1
locus and also confirmed the previously suggestive linkage
findings on chromosomes 7q and 8p (AIS2 and AIS3).
The study also provided supporting evidence for a disease
locus on chromosome 17, which likely corresponds to the
SLEV1 locus identified by Nath et al. (2001). Interest-
ingly, by stratifying their 102 families into autoimmunity-
and nonautoimmunity-associated groups, Spritz and col-
leagues (2004) found that, whereas the linkage evidence
at the AIS1, AIS2, and SLEV1 loci was mainly from the
autoimmunity-associated families, the evidence at the
AIS3 locus was primarily from the nonautoimmunity-
associated families, suggesting that generalized vitiligo
might be divided into two distinct phenotypic subcate-
gories that involve different disease loci or alleles. In ad-
dition to the genomewide linkage analyses, population-
based association analyses were used to investigate sever-
al candidate genes for vitiligo—for example, CTLA-4
(Kemp et al. 1999; Blomhoff et al. 2005), CAT and TAP1
(Casp et al. 2002, 2003), MC1R and ASIP (Na et al.
2003), ACE (Jin et al. 2004), and HLA (Zamani et al.
2001; Tastan et al. 2004; Zhang et al. 2004a).
Here, we report the first genomewide linkage analysis
of vitiligo in a Chinese population. Our family collection
includes 106 Chinese multiplex families, each with at least
two siblings affected with generalized vitiligo (table 1).
All the families were recruited by experienced dermatol-
ogists from the Department of Dermatology at First Af-
filiated Hospital of Anhui Medical University at Hefei,
Anhui, China, and from the Vitiligo Clinic of the Railway
Hospital at Xiangfan, Hubei, China. The diagnosis of
generalized vitiligo was made on the basis of the patient’s
history and the presence of typical clinical features (dis-
crete, well-circumscribed depigmented patches). Pheno-
types were carefully determined by history, lesion maps,
and, in most cases, physical examination and/or photo-
graphs. Any individual whose phenotype was question-
able was excluded from the study. Only patients with clear
signs of acquired patches on the extremities, trunk, gen-
italia, central face, or other areas were scored as affected.
The mean age at onset of the 286 affected individuals
(148 male [51.7%] and 138 female [48.3%]) from the
106 families was 18.6 years (range 1–63 years). Of the
106 families, 57 families were used in an initial genome-
wide linkage analysis, and 49 families were used in a
follow-up linkage analysis in which the initial linkage
findings from the genomewide scan were further inves-
tigated by use of dense marker coverage (table 1). For
each family, blood samples were collected from all af-
fected individuals, their parents, and additional family
members connecting affected individuals. Among the 106
families, blood samples were collected from both parents
in 81 families and from one parent in 17 families. Eight
families were missing samples from both parents of af-
fected individuals. When samples from one or both par-
ents of an affected individual were unavailable, a blood
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sample was collected from at least one additional unaf-
fected sibling. Informed consent was obtained from each
recruited subject. The study was approved by the Ethical
Committee of the Chinese National Human Genome Cen-
ter at Shanghai.
Genomic DNA was extracted from whole blood by
use of a simple salting-out procedure, as described else-
where (Miller et al. 1988). We performed a genomewide
linkage analysis of vitiligo by genotyping 382 microsat-
ellite markers from the ABI Prism Linkage Mapping Set
(version 2) in 57 families. Average marker spacing is 8.85
cM (range 1–19 cM), and average marker information
content is 0.72, on the basis of genotypes from the 57
families. All the marker positions were based on an in-
terpolated genetic map that incorporates the information
from a physical map (build 34.3) and from published
deCODE and Marshfield genetic maps (see David Duffy’s
QIMR Homepage). All the markers were genotyped in
multiplex PCR, in accordance with the manufacturer’s
guidelines (Applied Biosystems). Before being used in
linkage analysis, all genotyping data were subjected to
quality checking by use of the programs PedCheck
(O’Connell and Weeks 1998) and MERLIN (Abecasis
et al. 2002). Problematic genotypes either were corrected
by rechecking original allele callings or were removed if
allele status could not be reliably determined.
Both nonparametric and parametric linkage analyses
were performed using the program GENEHUNTER 2.1
(Kruglyak et al. 1996). For nonparametric analysis, the
NPL score was calculated using the Sall statistic to cap-
ture the information about allele sharing between all
affected individuals in a pedigree. For parametric anal-
ysis, the heterogeneity LOD (HLOD) score was calcu-
lated by assuming a dominant or recessive inheritance
of the disease allele and a disease-allele frequency of
0.01, consistent with the population prevalence of
0.19% in China (Xu et al. 2002). Moreover, to reduce
the impact of the nonpenetrant disease allele on link-
age analysis, genomewide parametric analysis was per-
formed by using an “affecteds-only” approach, in which
all normal individuals were treated as “unknown” in-
stead of “unaffected,” and by assuming a simple genetic
model with high penetrance (0.99) and very low phe-
nocopy rates (0.001). Marker-allele frequency was es-
timated on the basis of founders’ genotypes of either 57
families (for the genomewide analysis) or 106 families
(for the follow-up analysis) by use of the program Link-
age 5.10 (Lathrop and Lalouel 1984).
Multipoint nonparametric analysis identified linkage
signals on 1p36, 4q13-q21, 6p21-p22, 6q24-q25, 14q12-
q13, and 22q12 (fig. 1). Of these, the highest NPL score
was 3.05 ( ), identified at the marker intervalPp .0017
D6S308–D6S441 on 6q24-q25; this was followed by
NPL scores of 2.94 ( ) at the marker intervalPp .0021
D4S1592–D4S1534 on 4q13-q21, 2.87 ( ) atPp .0023
the marker interval D22S280–D22S283 on 22q12, 2.83
( ) at the marker interval D14S275–D14S70Pp .0026
on 14q12-13, 2.68 ( ) at the marker intervalPp .0044
D6S422–D6S273 on 6p21-p22, and 2.67 ( )Pp .0045
at the marker interval D1S234–D1S2885 on 1p36. Mul-
tipoint parametric linkage analysis under a recessive
model of inheritance identified suggestive evidence for
linkage (HLOD score of 1.86 or higher) (Lander and
Kruglyak 1995) on 4q12-q13, 5p15, 6q24-q25, and
8q24 (fig. 1). The most significant HLOD score under
a recessive model was 2.99 ( ) at the markerap 36%
interval D6S308–D6S441, which was followed by mul-
tipoint HLOD scores of 2.48 ( ) at the markerap 34%
interval D5S1981–D5S406, 2.15 ( ) at the mar-ap 38%
ker interval D8S284–D8S272, and 1.94 ( ) atap 28%
the marker interval D4S1592–D4S392. Under a domi-
nant model of inheritance, multipoint parametric analysis
identified suggestive linkage evidence on 2q13, 6p21-p22,
14q12-q13, and 22q12 (fig. 1). The highest HLOD score
of 2.28 ( ) was identified at marker D2S160,ap 59%
which was followed by HLOD scores of 2.26 (ap
) at the marker interval D6S422–D6S273, 2.1537%
( ) at the marker interval D14S275–D14S70,ap 48%
and 2.07 ( ) at the marker interval D6S308–ap 46%
D6S441. For both nonparametric and parametric ge-
nomewide linkage analyses, two-point LOD scores (da-
ta not shown) were consistent with the multipoint LOD
scores but were generally lower.
Our genomewide linkage analysis of vitiligo in the 57
Chinese families identified interesting linkage signals in
six genomic regions. The most significant evidence for
linkage was on 6q24-q25 and was supported by a max-
imum multipoint NPL score of 3.05 and a recessive
HLOD score of 2.99. The second-most significant evi-
dence was on 4q13-q21, with a maximum multipoint
NPL score of 2.94 and a recessive HLOD score of 1.94,
which was followed by linkage evidence on 6p21-p22,
with a maximum multipoint NPL score of 2.67 and a
dominant HLOD score of 2.26. Linkage evidence was
also identified on 1p36, 14q12-q13, and 22q12, but the
evidence was less significant (table 2). To further inves-
tigate these initial linkage findings, we analyzed an ad-
ditional 49 Chinese families recruited from the same clin-
ics in a follow-up analysis in which additional markers
were genotyped to extract more linkage information.
Instead of using the “affecteds-only” approach, we per-
formed the follow-up parametric analysis of the initial
linkage findings by assuming a disease-allele frequency
of 0.01, a variable penetrance rate (range 0.5–0.99), and
a fixed phenotype rate of 0.001 and by using the in-
heritance model under which the initial linkage evidence
was identified in the genomewide analysis. Changing the
penetrance rate made almost no impact on HLOD score
results (data not shown); therefore, only HLOD scores
under the penetrance rate of 0.99 were reported.
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Figure 2 Multipoint LOD scores on 4q13-q21 from the joint
linkage analysis of 106 families. Multipoint NPL scores (red line);
multipoint HLOD scores, under a recessive model of inheritance (black
line); and marker information content (blue line) are plotted.
The initial linkage finding on 4q13-q21 was further
investigated by genotyping 12 new and 5 original micro-
satellite markers in 106 families, which increased the
marker density to an average marker spacing of 3.3 cM.
We first performed a joint linkage analysis of 106 families,
including 57 original and 49 new families. Multipoint
linkage analysis of 17 markers yielded a maximum NPL
score of 4.62 ( ) at the marker intervalPp .000003
D4S392–D4S3042 and a maximum HLOD score of 4.01
( ) at the adjacent marker interval D4S3042–ap 31%
D4S2947, under a recessive model of inheritance (fig. 2
and table 2). The multipoint LOD score results were sup-
ported by a two-point analysis that yielded a maximum
two-point NPL score of 4.53 ( ) and a re-Pp .000004
cessive HLOD score of 5.97 ( ) at the markerap 42%
locus D4S392. Both nonparametric and parametric LOD
scores of the joint linkage analysis of the 106 families on
4q13-q21 surpassed the suggested genomewide criteria
for significant linkage evidence (Lander and Kruglyak
1995). In addition, we also performed an independent
linkage analysis of the same 17 markers in 49 new families
by using the same genetic model. The linkage analysis of
the 49 new families provided independent supporting evi-
dence for linkage, yielding a multipoint NPL score of
4.29 ( ) and an HLOD score of 2.74 (Pp .00001 ap
) at the same genetic position. Therefore, our initial35%
genomewide and subsequent fine-mapping linkage anal-
yses have identified a novel linkage to vitiligo on 4q13-
q21.
The two-point HLOD score at D4S392 is consider-
ably higher than the multipoint HLOD score. This is
not unexpected, because two-point linkage analysis is
known to be more prone than multipoint analysis to
inflated or deflated LOD scores. Marker information
content at the D4S392 locus is 0.61 in our families,
which is much lower than the marker information con-
tent of ∼0.9 that was achieved in our multipoint linkage
analysis (fig. 2). A less informative marker, which is more
likely to be present in two-point analysis than in mul-
tipoint analysis, can cause partial pedigrees to become
uninformative at the marker locus. When partial linked
or unlinked pedigrees become uninformative, the LOD
score will be deflated or inflated, respectively. This prob-
lem is largely responsible for the phenomenon of having
strong evidence for linkage to a single marker, without
evidence, or with much weaker evidence, for the flanking
markers.
The follow-up linkage analysis on 6p21-p22 was per-
formed by analyzing nine new and six original markers
in the 106 families and yielded a multipoint NPL score
of 3.16 ( ) at the marker interval D6S422–Pp .00092
D6S1660 and a parametric HLOD score of 2.14 (ap
) at the adjacent marker interval D6S1584– D6S422,32%
under the dominant model of inheritance (table 2). Two-
point nonparametric and parametric linkage analyses
also provided supporting evidence (data not shown).
Therefore, the follow-up linkage analysis of additional
families and markers increased the NPL score from 2.67
to 3.16, and the enhanced linkage evidence was only
slightly below the genomewide criteria for “suggestive
linkage” (Lander and Kruglyak 1995; Nyholt 2000).
Our linkage finding on 6p21-p22 is consistent with
the suggested autoimmune pathogenesis of vitiligo and
the involvement of the major histocompatibility complex
(MHC) locus in genetic predisposition to vitiligo. Au-
toimmune pathogenesis of vitiligo has been suggested by
both clinical and immunological observations (Kovacs
1998; Ongenae et al. 2003; Le Poole et al. 2004). For
example, vitiligo is associated with other autoimmune
disorders in many patients. Immunological studies also
demonstrated that autoantibodies to melanocytes can be
detected, and depigmentation of skin is often accom-
panied by T-cell infiltration to the skin in many patients
with vitiligo (Wankowicz-Kalinska et al. 2003). More-
over, repigmenting therapies are often associated with
an immunosuppressive effect. All of these observations
provide direct and indirect supporting evidence for an
autoimmunity-mediated pathogenesis of vitiligo. Be-
cause of the extensive pathogenic association of the MHC
locus with a large number of autoimmune disorders (Hor-
ton et al. 2004), the involvement of the MHC genes in
the pathogenesis of vitiligo was suspected and was in-
tensively investigated by genetic association analysis.
Candidate gene–based genetic association analyses of
vitiligo in Chinese (Zhang et al. 2004a) and white pop-
ulations (Venneker et al. 1992; Zamani et al. 2001; Ar-
cos-Burgos et al. 2002; de Vijlder et al. 2004; Tastan et
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al. 2004) have revealed multiple evidence for association
between alleles of the MHC genes and vitiligo. There-
fore, our linkage finding on 6p21-p22 was probably not
unexpected, and it provides additional linkage evidence
for the involvement of the MHC region in genetic risk
of vitiligo. Moreover, our result also supports the sug-
gestion that vitiligo shares some genetic risk factors with
other autoimmune disorders (Spritz et al. 2004).
The linkage signal on 1p36 from the genomewide
analysis was further investigated by analyzing six new
and five original markers in 106 families. The follow-
up linkage analysis of the 106 families yielded a mul-
tipoint NPL score of 2.37 ( ) and a multipointPp .009
recessive HLOD score of 1.17 at the marker interval
D1S2734–D1S234 (table 2), which failed to strengthen
the original linkage evidence on 1p36. Our moderate
linkage evidence on chromosome 1p is at least 30 cM
away from the AIS1 locus that was identified in the white
population (Alkhateeb et al. 2002; Fain et al. 2003;
Spritz et al. 2004). Therefore, our linkage analysis in
Chinese families did not provide supporting evidence for
this previously identified linkage on 1p in the white pop-
ulation. The linkage findings on 6q24-q25, 14q12-q13,
and 22q12 were also further investigated in the 106
families, but none of these linkage findings was enhanced
by the follow-up analysis of additional families (table
2).
Our linkage findings in the Chinese population show
a minimal overlap with the previous linkage findings in
white populations. Except for the 6p21-p22 region, our
findings (highly significant linkage on 4q13-q21 and
moderate linkage on 1p36, 6q24-q25, 14q12-q13, and
22q12) are all novel and were not reported in previous
genomewide linkage analyses of white populations. Fur-
thermore, previously identified strong linkage evidence
on 1p31 (AIS1) (Alkhateeb et al. 2002; Fain et al. 2003;
Spritz et al. 2004), 7q (AIS2), and 8p (AIS3) (Spritz et
al. 2004) in the white population received little, if any,
supporting evidence from our current linkage analysis
of Chinese families. Such little overlap between the link-
age findings in Chinese and white populations is very
intriguing and might suggest that vitiligo is associated
with strong genetic heterogeneity and that it involves
different genetic risk factors in different ethnic popula-
tions. Meanwhile, we still need to keep in mind that it
is possible that the current and previous linkage findings
are largely false positives, which could account for the
small amount of overlap in linkage findings. However,
considering the high statistical significance of our linkage
finding on 4q13-q21 in Chinese families and the pre-
vious linkage findings on 1p31 (AIS1), 7q (AIS2), and
8p (AIS3) in white families, we reason that this possi-
bility is unlikely, although it can not be totally ruled out.
Moreover, we hypothesize that there may be a significant
difference in the genetic basis of vitiligo between Chinese
and white populations. Such a difference in linkage re-
sults between Chinese and white populations can also
be seen in studies of psoriasis, another autoimmune skin
disorder (Gudjonsson et al. 2004), in which the 4q28-
q31 region was recently recognized as a strong candidate
region for hosting a susceptibility gene for psoriasis
(Bowcock 2004). Linkage to psoriasis on 4q28-q31 was
identified with highly significant evidence in a genome-
wide linkage analysis of Chinese families (Zhang et al.
2002) but not in any of five previous genomewide link-
age analyses of white families. Independent supporting
evidence for this linkage emerged only after the five
white population–based genomewide linkage studies
were pooled together in a meta-analysis (Sagoo et al.
2004). This suggests that, although the as-yet-uniden-
tified susceptibility gene within the 4q28-q31 region is
a major susceptibility gene that contributes significantly
to genetic risk of psoriasis in the Chinese population, it
probably contributes much less in the white popula-
tion and thus can only be detected by the analysis of a
very large number of families. An interesting question
is whether the same is true for the linkage to vitiligo on
4q13-q21. Additional linkage studies in Chinese and
white populations will likely shed light on this question.
In summary, we have performed the first genomewide
linkage study of vitiligo in a Chinese population. We have
identified linkage evidence in several genomic regions, and
the evidence on 4q13-q21 has been confirmed by our
follow-up analysis of additional new families. Not only
has the overall linkage evidence from the joint linkage
analysis of the 106 families surpassed the genomewide
criteria for “significant linkage,” but the linkage results
from the follow-up linkage analysis of the 49 new families
also have provided independent evidence for linkage. Our
linkage results strongly suggest that the 4q13-q21 region
likely harbors a major susceptibility locus for vitiligo
and should be targeted as a candidate for disease-gene
discovery.
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